FAQ/Help |
Calendar |
Search |
Today's Posts |
05-20-2013, 03:40 PM | #1 | |||
|
||||
Member
|
|
|||
Reply With Quote |
"Thanks for this!" says: | soccertese (05-20-2013) |
05-20-2013, 04:18 PM | #2 | |||
|
||||
Wisest Elder Ever
|
There are some posts here about Byetta and PD... already.
Seems kind of risky to me... with the pancreatitis risk. Patients with diabetes have rather become scarce... besides due to the side effect profile. But it is interesting since it involve glucose control.
__________________
All truths are easy to understand once they are discovered; the point is to discover them.-- Galileo Galilei ************************************ . Weezie looking at petunias 8.25.2017 **************************** These forums are for mutual support and information sharing only. The forums are not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Always consult your doctor before trying anything you read here.
|
|||
Reply With Quote |
05-20-2013, 04:57 PM | #3 | ||
|
|||
Senior Member
|
See also:
"Parkinson's disease, insulin resistance and novel agents of neuroprotection." Aviles-Olmos I, Limousin P, Lees A, Foltynie T. Brain. 2013 Feb;136(Pt 2):374-84. doi: 10.1093/brain/aws009. Epub 2012 Feb 17. http://www.ncbi.nlm.nih.gov/pubmed/22344583 "Multiple avenues of research including epidemiology, molecular genetics and cell biology have identified links between Parkinson's disease and type 2 diabetes mellitus. Several recent discoveries have highlighted common cellular pathways that potentially relate neurodegenerative processes with abnormal mitochondrial function and abnormal glucose metabolism. This includes converging evidence identifying that peroxisome proliferator activated receptor gamma coactivator 1-α, a key regulator of enzymes involved in mitochondrial respiration and insulin resistance, is potentially pivotal in the pathogenesis of neurodegeneration in Parkinson's disease. This evidence supports further study of these pathways, most importantly to identify neuroprotective agents for Parkinson's disease, and/or establish more effective prevention or treatment for type 2 diabetes mellitus. In parallel with these advances, there are already randomized trials evaluating several established treatments for insulin resistance (pioglitazone and exenatide) as possible disease modifying drugs in Parkinson's disease ..." Perhaps we should spend more time discussing the relationship between PD progression and diet. John
__________________
Born 1955. Diagnosed PD 2005. Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg |
||
Reply With Quote |
"Thanks for this!" says: | GerryW (05-21-2013) |
05-20-2013, 06:36 PM | #4 | ||
|
|||
Member
|
This is interesting Gerry. There is another current PD study ongoing with Pioglitazone (another type 2 diabetes drug). I was originally participating in the study but dropped out after meeting with the research team. The potential side effects concerned me and I wasn't convinced on the risk vs reward.
|
||
Reply With Quote |
"Thanks for this!" says: | soccertese (05-21-2013) |
05-20-2013, 10:59 PM | #5 | |||
|
||||
Senior Member
|
This side effect has been known about for a long time:
http://neurotalk.psychcentral.com/sh...ghlight=byetta
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
05-21-2013, 01:38 AM | #6 | ||
|
|||
Member
|
Are getting quite excited about this, see below for the Parkinson's UK web site.
http://www.parkinsons.org.uk/about_u...l_results.aspx Do we share the excitement or not ? Neil. |
||
Reply With Quote |
05-21-2013, 09:44 AM | #7 | ||
|
|||
Senior Member
|
Quote:
In the meantime John's question about PD and diet also stands. It is a subject that has been discussed in this forum many times. http://www.cureparkinsons.org.uk/News/exenatide |
||
Reply With Quote |
"Thanks for this!" says: | soccertese (05-21-2013) |
05-21-2013, 02:36 PM | #8 | |||
|
||||
Legendary
|
Posting for your information...
This was on one of our news channels in Australia last night. Video shows short footage of one patient from the trial - Arthur Lindley. http://au.news.yahoo.com/video/natio...sons-progress/ Drug slows Parkinson's progress I was surprised that only 20 people received the drug in the actual trial. http://www.uclh.org/News/Pages/Diabe...spatients.aspx Quote:
|
|||
Reply With Quote |
05-21-2013, 08:50 PM | #9 | |||
|
||||
In Remembrance
|
And for a lot of reasons ranging from horny gila monsters under a desert sky to new territory with the promise of great riches to come. I watched it with great interest before it disappeared into the Clinic and am glad to see it return. I checked with File Mountain (aka my hard disk) and found that there was indeed a lot to the buzz. I will just touch on it here and will bring out more as time goes on if there is interest.
One thing is that, as noted above, the work is being pushed by the Cure Parkinson's Trust and its honcho Tom Isaacs who is sort of England's MJ Fox. Tom found out that he was thought to have PD and immediately went on the offensive with a scheme to walk around the coast of Britain to raise research funds. He accomplished it very well and set up a foundation which he directs. Totally patient controlled and dedicated to getting results not tenure. There is also the fact that they have chosen to focus on an existing and approved drug. I see this as vitally important in that the time between something major being described and we PDers standing at our local pharmacy with a Script in hand drops from a few decades to a few weeks! My GP has already agreed that if things start looking even more positive that he will be happy to write the order for me. I am going to try to pull together a summary of why and what. As I remember, there is a peptide produced when you eat. That peptide streams out into the system and begins to act as a stimulant for neurogenesis and as a neurtropic guide. But the peptide is destroyed almost immediately by an enzyme. When they were able to accomplish all those blocking actions in a mouse they found that they had some very happy little rodents with no PD to be seen. Thus the interest and the excitement. -Rick
__________________
Born in 1953, 1st symptoms and misdiagnosed as essential tremor in 1992. Dx with PD in 2000. Currently (2011) taking 200/50 Sinemet CR 8 times a day + 10/100 Sinemet 3 times a day. Functional 90% of waking day but fragile. Failure at exercise but still trying. Constantly experimenting. Beta blocker and ACE inhibitor at present. Currently (01/2013) taking ldopa/carbadopa 200/50 CR six times a day + 10/100 form 3 times daily. Functional 90% of day. Update 04/2013: L/C 200/50 8x; Beta Blocker; ACE Inhib; Ginger; Turmeric; Creatine; Magnesium; Potassium. Doing well. |
|||
Reply With Quote |
"Thanks for this!" says: | lindylanka (05-21-2013) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
New drug slows Alzheimer’s in mice--derived from curcumin | Parkinson's Disease | |||
New Alzheimers drug slows progression 81% and.... it CAN'T be patented | Parkinson's Disease | |||
ALS Drug Slows Melanoma Growth | ALS News & Research | |||
Drug slows and may halt Parkinson's disease | Parkinson's Disease |